Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 8.72
+0.06 (0.69%)
At close: Jul 31, 2026
SHE:301301 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 4,414 | 4,616 | 5,758 | 4,823 | 3,821 | 3,232 |
Revenue Growth | -20.21% | -19.83% | 19.38% | 26.24% | 18.21% | -11.44% |
Gross Profit Gross Profit Growth | 1,100 | 1,326 | 2,078 | 1,480 | 930.89 | 595.07 |
Operating Income Operating Income Growth | 765.25 | 971.68 | 1,737 | 1,186 | 670.77 | 396.8 |
Net Income Net Income Growth | 591.52 | 769.01 | 1,400 | 940.56 | 411.52 | 111.35 |
Earnings Per Share EPS Growth | 0.26 | 0.34 | 0.63 | 0.42 | 0.21 | 0.06 |
EPS Growth | -56.41% | -46.03% | 50.00% | 100.00% | 250.00% | -45.45% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medicine Manufacturing Medicine Manufacturing Growth | 4,024 | 4,227 | 5,397 | 4,515 | 3,574 | 3,055 |
Unallocated Other Unallocated Other Growth | - | 389.55 | 361.61 | 308.58 | 246.72 | 177.08 |
Total Total Growth | 4,414 | 4,616 | 5,758 | 4,823 | 3,821 | 3,232 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 664.17 | 734.21 | 1,088 | 760.94 | 1,633 | 511.26 |
Total Debt Total Debt Growth | 1,219 | 1,187 | 1,424 | 1,938 | 3,266 | 3,675 |
Net Cash (Debt) Net Cash Growth | -554.94 | -452.44 | -336 | -1,177 | -1,633 | -3,163 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.25 | -0.20 | -0.15 | -0.53 | -0.83 | -1.70 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 615.16 | 549.06 | 1,791 | 1,292 | 691.64 | 803.21 |
Capital Expenditures CapEx Growth | -104.04 | -97.21 | -42.6 | -345.13 | -47.2 | -52.27 |
Free Cash Flow Free Cash Flow Growth | 511.11 | 451.85 | 1,748 | 947.26 | 644.44 | 750.94 |
Free Cash Flow Growth | -68.82% | -74.16% | 84.58% | 46.99% | -14.18% | 33.96% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 24.92% | 28.73% | 36.09% | 30.69% | 24.37% | 18.41% |
Operating Margin | 17.34% | 21.05% | 30.16% | 24.59% | 17.56% | 12.28% |
Pretax Margin | 16.48% | 20.33% | 29.09% | 23.17% | 12.76% | 4.15% |
Profit Margin | 13.40% | 16.66% | 24.32% | 19.50% | 10.77% | 3.45% |
FCF Margin | 11.58% | 9.79% | 30.36% | 19.64% | 16.87% | 23.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.173 | 0.173 | 0.270 | 0.225 | 0.093 |
Dividend Per Share Growth | -35.84% | -35.93% | 20.00% | 141.94% | - |
Dividend Yield | 1.98% | 1.74% | 2.37% | 2.83% | 1.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 33.33 | 29.41 | 18.86 | 19.85 | 48.34 | - |
Forward PE | 21.27 | 22.87 | 16.86 | 20.74 | - | - |
P/FCF Ratio | 38.08 | 50.05 | 15.11 | 19.71 | 30.87 | - |
PS Ratio | 4.41 | 4.90 | 4.59 | 3.87 | 5.21 | - |